People: Synta Pharmaceuticals Corp (SNTA.OQ)

SNTA.OQ on NASDAQ Stock Exchange Global Market

3.06USD
4:00pm EDT
Price Change (% chg)

$-0.07 (-2.24%)
Prev Close
$3.13
Open
$3.14
Day's High
$3.16
Day's Low
$3.00
Volume
320,620
Avg. Vol
418,696
52-wk High
$7.22
52-wk Low
$2.62

Search Stocks

Ehrlich, Keith 

Brief Biography

Mr. Keith S. Ehrlich, CPA, is Chief Financial Officer, Vice President - Finance and Administration of Synta Pharmaceuticals Corp. From November 2003 to February 2004, Mr. Ehrlich served as a financial consultant to the Company. From September 1999 to April 2003, Mr. Ehrlich was Vice President, Finance and Administration and Chief Financial Officer and Treasurer at Argentys Corporation, a private software development company. From January 1998 to July 1999, Mr. Ehrlich served as Senior Vice President, Finance and Administration, Chief Financial Officer and Treasurer of Dyax Corp., a publicly traded biopharmaceutical company. From October 1993 to January 1998, he served as Vice President, Finance and Administration and Chief Financial Officer and Treasurer of Oravax, Inc., a publicly traded biopharmaceutical company since acquired by Acambis plc. From May 1991 to October 1993, he served as Treasurer and Director of Finance of Vertex Pharmaceuticals, Inc., a publicly traded biopharmaceutical company. From January 1980 to April 1991, Mr. Ehrlich was an auditor with Coopers & Lybrand LLP. Mr. Ehrlich received his B.A. in Biology from Drew University and his M.B.A. in Finance and Accounting from Rutgers University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
349,667 -- 414,230 763,897

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable 54,545 218,180.00
Exercised -- --
Name Fiscal Year Total

Keith Gollust

--

Keith Ehrlich

763,897

Arthur McMahon

--

Vojo Vukovic

900,181

Wendy Rieder

622,938

Paul Friedman

--
As Of 30 Dec 2013
Search Stocks